LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Polestar Automotive Holding UK PLC ("Polestar" or "the Company") (NASDAQ:PSNY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 14, 2022 and January 16, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.

image for news The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Polestar Automotive Holding UK PLC

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.

image for news The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 2, 2023, and February 27, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.

image for news Integral Ad Science Holding Corp. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

Air Products' Industry Experts will Present the Details of Recent Hydrogen Boiler Trials, as well as Information on Hydrogen's Role in Enhancing Microgrid Resilience LEHIGH VALLEY, Pa. , Feb. 10, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will highlight how its industrial gases, such as hydrogen, can help the power industry generate a cleaner future and reach its decarbonization goals at POWERGEN International, from February 11-13, at the Kay Bailey Hutchison Convention Center in Dallas, Texas.

image for news Air Products to Showcase Industrial Decarbonization Solutions at POWERGEN International in Dallas, Texas

Coles Supermarkets is the first retailer in the Asia Pacific region to deploy Caper Carts, Instacart's AI-powered smart trolleys SAN FRANCISCO and MELBOURNE, Australia , Feb. 10, 2025 /PRNewswire/ -- Instacart (NASDAQ: CART), the leading grocery technology company in North America, and Coles Supermarkets (ASX: COL), one of Australia's leading retailers, today announced the rollout of Caper Carts, Instacart's AI-powered smart trolleys, at its Richmond Traders location in Melbourne. Customers can now shop smarter, bag as they shop, and pay directly on the Coles Smart Trolley for a seamless in-store shopping experience.

image for news Instacart's Smart Trolleys are Now Available at Coles Supermarkets in Australia

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 10, 2025.

image for news The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc.

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 14, 2024 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.

image for news Cardlytics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news The Schall Law Firm Invites Investors With Losses In Celanese Corporation To Join A Securities Fraud Investigation

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Red Cat Holdings, Inc. ("Red Cat" or "the Company") (NASDAQ:RCAT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news Red Cat Holdings, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") (NASDAQ:CRGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news CARGO Therapeutics, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

PHILADELPHIA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of Monolithic Power Systems, Inc. (NASDAQ: MPWR) shareholders. The investigation concerns whether certain officers and directors of Monolithic have breached their fiduciary duties owed to the company.

image for news Long-Term Monolithic Power Systems, Inc. (Nasdaq: MPWR) Shareholders are Encouraged to Contact Grabar Law Office

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term — Positive

DGX   Zacks Investment Research — February 10, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

EnerSys (ENS) is a Top-Ranked Momentum Stock: Should You Buy? — Positive

ENS   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news EnerSys (ENS) is a Top-Ranked Momentum Stock: Should You Buy?

Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term — Positive

ENSG   Zacks Investment Research — February 10, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term

Why Clearway Energy (CWEN) is a Top Momentum Stock for the Long-Term — Positive

CWEN   Zacks Investment Research — February 10, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why Clearway Energy (CWEN) is a Top Momentum Stock for the Long-Term

Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock — Positive

RCL   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock

Here's Why Logitech (LOGI) is a Strong Momentum Stock — Positive

LOGI   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Logitech (LOGI) is a Strong Momentum Stock

What to Expect From Service Corporation in Q4 Earnings Release? — Positive

SCI   Zacks Investment Research — February 10, 2025

SCI's Q4 results are likely to reflect gains from a resilient business model and favorable demographics.

image for news What to Expect From Service Corporation in Q4 Earnings Release?

Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet — Positive

RGNX   Zacks Investment Research — February 10, 2025

The consensus price target hints at a 333% upside potential for Regenxbio (RGNX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet

Hercules Capital: Hybrid Strategy Crafts A BDC Winner — Positive

HTGC   Seeking Alpha — February 10, 2025

Hercules Capital brings a conservative yet flexible BDC strategy and a focus on innovative companies as dealmaking targets. The leadership team boasts extensive and varied financial experience. Its track record should create confidence for investors. Hercules' business strategy is based on a selective approach to dealmaking, consistent liquidity maintenance and flexible loan structuring fit to target company situations.

image for news Hercules Capital: Hybrid Strategy Crafts A BDC Winner